Shalini Sharp

2013 - Ultragenyx Pharmaceutical

In 2013, Shalini Sharp earned a total compensation of $625.2K as Chief Financial Officer and Senior Vice President at Ultragenyx Pharmaceutical, a 106% increase compared to previous year.

Compensation breakdown

Bonus$30,000
Non-Equity Incentive Plan$110,206
Option Awards$182,394
Salary$278,440
Other$24,193
Total$625,233

Sharp received $278.4K in salary, accounting for 45% of the total pay in 2013.

Sharp also received $30K in bonus, $110.2K in non-equity incentive plan, $182.4K in option awards and $24.2K in other compensation.

Rankings

In 2013, Shalini Sharp's compensation ranked 8,578th out of 12,286 executives tracked by ExecPay. In other words, Sharp earned more than 30.2% of executives.

ClassificationRankingPercentile
All
8,578
out of 12,286
30th
Division
Manufacturing
3,116
out of 4,612
32nd
Major group
Chemicals And Allied Products
979
out of 1,462
33rd
Industry group
Drugs
744
out of 1,156
36th
Industry
Pharmaceutical Preparations
590
out of 890
34th
Source: SEC filing on April 18, 2016.

Sharp's colleagues

We found two more compensation records of executives who worked with Shalini Sharp at Ultragenyx Pharmaceutical in 2013.

2013

Emil Kakkis

Ultragenyx Pharmaceutical

Chief Executive Officer

2013

Thomas Kassberg

Ultragenyx Pharmaceutical

Senior Vice President and Chief Business Officer

News

You may also like